Skye Bioscience, Inc.SKYENASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+149.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+149.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
96.2x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$180009.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$1872.00+28.0%
2019$1462.00-5.3%
2018$1544.00-80.8%
2017$8038.00-46.1%
2016$14916.00-